SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries informs about annual secretarial compliance report

30 May 2026 Evaluate
Pursuant to Regulation 24A of SEBI Listing Regulations read with SEBI Circular no. CIR/CFD/CMD7 27l2ol9 dated 8th February, 2019, Sudarshan Pharma Industries has enclosed the Annual Secretarial Compliance Report issued by Vishal Manseta, Company Secretary in Practice, for the financial year ended 31st March 2026.

The above information is a part of company’s filings submitted to BSE. 

Sudarshan Pharma (I) Share Price

36.53 -1.36 (-3.59%)
03-Jul-2026 12:00 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1911.55
Dr. Reddys Labs. 1375.20
Cipla 1461.25
Zydus Lifesciences 1127.60
Lupin 2468.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: